US-based organics group Hain Celestial lowered its full-year guidance yesterday (4 February) as it saw its second-quarter profits tumble.


For the period ended 31 December, net income declined 48% to US$8.1m, hurt by inventory reductions, grain costs and a lag in realising price increases.


Sales rose 14% to $315.6m from $276.2m in the comparable period of the previous year.


Hain said inventory reductions, grain costs at Hain Pure Protein and the lag in fully realising an August price increase impacted earnings by almost $0.11 per share this quarter.


“Despite a strong start in the quarter, sales moderated toward the end of the quarter with the acceleration of the economic downturn. Although there is evidence that some customers are reducing their inventories and some consumers are destocking their pantries, we continue to see growth in key categories, supported by our innovative new products,” said president and CEO Irwin Simon.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

For fiscal 2009, the company now expects sales to be in the range of $1.175-1.2bn and earnings of $1.38-1.42 per share.


Earlier, the company expected its fiscal year 2009 guidance of $1.2-1.3bn in sales and $1.54 to $1.61 in earnings per share.